NCT04296318View on ClinicalTrials.gov

COPD Exacerbation Alert System With urinE anaLysis Using the HEADSTART Device

TerminatedOBSERVATIONAL
Enrollment

86

Participants

Timeline

Start Date

November 19, 2019

Primary Completion Date

February 15, 2022

Study Completion Date

July 24, 2022

Conditions
COPD Exacerbation
Trial Locations (1)

LE3 9QP

Institute for Lung Health, Glenfield Hospital, Leicester

Sponsors

Lead Sponsor

Mologic Ltd
All Listed Sponsors
collaborator

University Hospitals, Leicester

OTHER

lead

Mologic Ltd

INDUSTRY

NCT04296318 - COPD Exacerbation Alert System With urinE anaLysis Using the HEADSTART Device | Biotech Hunter | Biotech Hunter